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Association between organ dysfunction and 
cytokine concentrations during the early phases of 
septic shock
Associação entre a evolução da disfunção orgânica e as concentrações 
de citocinas na fase inicial do choque séptico
INTRODUCTION
Sepsis is characterized by the activation of pro-inflammatory and anti-
inflammatory cytokines.(1) After the inflammatory response starts, several mechanisms 
are activated by cytokines, e.g., inflammatory cell recruitment, endothelial 
cell activation, vasodilation, increased capillary permeability, microcirculation 
thrombosis, increased free radical production, the exacerbation of apoptosis and 
an impairment of mitochondrial function causing cytopathic hypoxia.(2,3) These 
factors may contribute to reduced oxygen availability or consumption, leading to, 
or aggravating, organ dysfunction. A concomitant anti-inflammatory response is, in 
turn, necessary for a return to homeostasis. Therefore, anti-inflammatory cytokines 
also have their role in the natural history of this disease.
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ABSTRACT
Objective: To investigate the 
correlation of organ dysfunction and its 
progression with inflammatory response 
during the early phases of septic shock by 
assessing baseline cytokine concentrations.
Methods: This study included 
patients over 18 years old with septic 
shock within the first 48 hours after the 
onset of organ dysfunction. Interleukin 
6 (IL-6), interleukin 8 (IL-8), interleukin 
10 (IL-10) and C-reactive protein levels 
were assessed at inclusion and after 24 
hours, and the differences between these 
values were calculated. The progression 
of organ dysfunction was assessed using 
the Sequential Organ Failure Assessment 
(SOFA) score upon admission and 24 
hours later for a delta-SOFA determination 
and were categorized as either worsened 
or improved. The results were expressed 
as means + standard deviation or median 
(25–75% percentiles). Values with 
descriptive p values of 0.05 or less were 
considered significant.
Results: Overall, we included 41 
patients with median SOFA scores of 
8.0 (6.5–10.0) upon admission (T0) 
and 8.0 (6.0–10.0) 24 hours later (T1). 
Worsened, improved or unchanged 
SOFA scores were observed in 11 
(Group 1), 17 (Group 2) and 13 (Group 
3) patients, respectively. For Group 1, 
the baseline IL-6, IL-8 and IL-10 values 
were higher, and a significant increase 
of IL-8 levels was found after 24 hours. 
The change in the SOFA score after 24 
hours was significantly, although weakly, 
correlated with baseline IL-6 and IL-8 
concentrations. 
Conclusions: Higher baseline IL-
6, IL-8 and IL-10 levels are associated 
with unfavorable organ dysfunction 
outcomes. Increased IL-8 levels within 
the first 24 hours are correlated with a 
worsening dysfunction. 
Keywords: Shock, septic; Multiple 
organ fa i lure/et io logy;  Systemic 
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Several previous studies have focused on the 
determination of plasma cytokine concentrations (both 
pro-inflammatory and anti-inflammatory) in sepsis.(4-8) 
In addition, other investigators aimed to correlate these 
concentrations with patient prognoses, particularly with 
mortality. During the initial phases of sepsis, IL-6, IL-8, IL-
10 or TNF-α concentrations were shown to be increased 
in non-survivors when compared with survivors.(8,9) 
Bozza et al. reported that cytokine concentrations were 
accurate predictors of death within the first 48 hours (IL-6 
and IL-8) or within 28 days (IL-8).(10) 
In addition to this clear implication in mortality, other 
studies have focused on correlating baseline cytokine 
concentrations with sepsis phase(9) or the severity of 
organ dysfunction as assessed both by Multiple Organ 
Dysfunction Score (MODS)(11) and Sequential Organ 
Failure Assessment (SOFA) scores.(10,12) However, the 
dynamic course of baseline cytokine concentrations and 
their correlation with the course of organ dysfunction 
remain to be clarified.(9,10,13) Several studies have shown 
that the course of organ dysfunction following the first 
day of therapy is a key outcome determinant.(14-16) An 
analysis of the association between organ dysfunction 
and cytokine concentrations may contribute to a better 
understanding of this condition. Therefore, this study 
aimed to investigate the correlation of the progression of 
organ dysfunction and inflammatory response by assessing 
baseline cytokine concentrations during the early phases 
of septic shock. 
METHODS
We assessed patients with septic shock who were 
admitted to the intensive care unit of the Discipline of 
Anesthesiology, Pain and Intensive Care, Universidade 
Federal de São Paulo, São Paulo, Brazil from February, 
2007 to August, 2009. This study was approved by the 
institution’s ethics committee, and all patients or their legal 
representatives signed an informed consent form (ICF). 
This sample was initially selected for inclusion in a study 
aimed at investigating the association between changes in 
coagulation and hyperglycemia in sepsis. Therefore, the 
inclusion and exclusion criteria were appropriate for that 
study. Patients over 18 years old who were diagnosed with 
septic shock within the first 48 hours after the onset of 
organ dysfunction and had signed an ICF were eligible for 
inclusion. Septic shock was defined according to the 1992 
consensus criteria.(17) We excluded patients known to be 
diabetic or using full-dose heparin, oral anticoagulants, 
thrombolytic drugs or activated C protein, those who 
had received platelet or plasma transfusions within seven 
days or were receiving insulin at the time of inclusion, 
those who had a episode of sepsis in the previous 30 days, 
coagulopathy not related with sepsis or intermediate 
glycemic levels (between 150 mg/dL and 200 mg/dL) at 
inclusion. 
For all patients, blood samples were collected from the 
arterial line at baseline for the measurement of inflammatory 
markers, interleukin 6 (IL-6), interleukin 8 (IL-8), 
interleukin 10 (IL-10) and C-reactive protein (CRP). New 
samples were drawn 24 hours later and analyzed for the 
same markers. Blood samples were preserved on ice and 
transported to the immunology laboratory, where they 
were processed and stored at -80ºC for later analysis. 
All interleukins were determined by Enzyme-Linked 
Immunoabsorbent Assay (ELISA) (BD Bioscience®) using 
specific antibodies. Ultrasensitive C-reactive protein was 
determined by turbidimetry (Roche®).
Patient demographic data were collected along with 
data on the sepsis process and its severity using the Acute 
Physiology and Chronic Health Evaluation (APACHE)(18) 
and Sequential Organ Failure Assessment (SOFA)(19) 
scores. The progression of organ dysfunction was assessed 
using the SOFA score taken 24 hours later to determine 
the delta SOFA (SOFAD1 – SOFAD0). The delta SOFA 
variable was later categorized. Improving or worsening 
conditions were considered as changes of plus or minus 
one point, respectively, based on previous studies showing 
an association between this degree of change and clinical 
outcomes.(14-16)
The values of the differences in cytokine and CRP 
levels were transformed into delta percentages, calculated 
as ratios of the T1 to T0 values times 100, to express 
percentage changes (Delta% = (D1/D0) * 100). As the 
standard deviations from the mean were above 40% for 
all the variables, deltas were also calculated as T1 minus 
T0 (Deltasub = D1 – D0). Additionally, values for the 
individual cytokines were expressed as logarithmic scales, 
and their deltas were calculated by subtraction. 
Statistical analysis
Continuous variables values were expressed as means 
+ standard deviation or medians (25–75% percentiles), 
depending on their distributions. The distribution 
normality was assessed using the Kolmogorov-Smirnov 
test, and the variance homogeneity was assessed using 
Bartlett’s test. Cytokines and CRP values for the different 
delta-SOFA categories were compared using the Kruskall-
Wallis test for both the absolute and log-transformed 
values, followed by Dunn test. 
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Possible associations between deltaSOFA and the 
baseline values of the various cytokine and CRP deltas 
were assessed using Spearman’s correlation test; the results 
were expressed as r values. Possible associations with 
several severity-related variables were also assessed, i.e., the 
APACHE II score, lactate at admission and the number of 
organ dysfunctions.
The Epi Info version 3.5.1 and the SPSS v. 17.0 
software packages were used for the statistical analysis. 
Values with descriptive p values of less than 0.05 were 
considered significant.
RESULTS
Forty-one patients were included in the study; 65.9% 
were male, and the mean patient age was 61.5 + 18.0 years. 
The main causes for admission to the ICU were infection-
related medical conditions (51.2%) followed by urgent 
surgery (29.3%) and elective surgery (19.5%). Most of the 
patients had comorbidities (63.4%). The most frequent 
source of infection were the lung (68.3%) and abdomen 
(22.0%) followed by urinary tract (7.3%) and bloodstream 
(2.4%). Nosocomial infections were more frequent (63.4%) 
than community-acquired infections (36.6%). The median 
APACHE II score was 14.0 (10.0–23.5). Most of the 
patients (85.3%) had three or more organ dysfunctions. The 
overall mortality rate was 61%. The patients’ demographic 
characteristics are listed in table 1.
The median SOFA score upon admission was 8.0 
(6.5–10.0); the T1 values were similar (8.0 (6.0–10.0). 
Eleven patients (26.8, Group 1) showed worsening organ 
dysfunction [deltaSOFA: 1.0 (1.0–2.0)], 17 patients 
(41.5%, Group 2) showed improving dysfunction 
(deltaSOFA: -1.0 (-2.0 to -1.0)], and 13 patients (31.7%, 
Group 3) had no changes in their dysfunction. The median 
deltaSOFA was 0.0 (-1.0 to 1.0). 
When SOFA variations were categorized, significant 
inter-group differences were observed in the baseline IL-
6, IL-8 and IL-10 levels. Patients with worsened SOFA 
had higher baseline concentrations of these cytokines 
(at inclusion) when compared with patients showing 
improvement and patients with unchanged dysfunction. 
Patients with worsened SOFA displayed a significant 
increase of IL-8 levels after 24 hours. No other significant 
inter-group differences were observed in changes in cytokine 
levels within the first 24 hours after admission, even when 
their log-transformed values were analyzed (Table 2). 
When the initial SOFA score and its change after 24 
hours were analyzed as a continuous variable (Table 3), 
a marginally significant correlation was observed between 
the SOFA changes and baseline IL-6 (Figure 1) and IL-8 
(Figure 2) levels. 
Table 1 - Patient demographics and infectious process characteristics according to the SOFA score variation between admission 
and the first day of progression
Variable Group 1
(N=11)
Group 2
(N=17)
Group 3
(N=13)
p value
Age 58.0 (51.0–69.0) 66.0 (53.5–76.5) 57.0 (33.0–85.00) 0.725
Gender
Male 6 (54.5) 14 (82.4) 7 (53.8) 0.157
Female 5 (45.5) 3 (17.6) 6 (46.2)
APACHE II 12.0 (9.0–18.0) 14.0 (11.8–26.0) 14.0 (10.0–22.5) 0.545
SOFA
T0 7.0 (6.0–8.0) 8.0 (6.5–11.0) 8.0 (8.0–10.0) 0.122
T1 8.0 (7.0–10.0) 6.0 (5.0–9.0) 8.0 (8.0–10.0) 0.131
Lactate T0 (mg/dL) 19.0 (12.0–30.0) 15.8 (12.4–24.0) 13.6 (8.6–23.8) 0.415
Delta SOFA 1.0 (1.0–2.0) -1.0 (-2.0 – -1.0) 0.0 0.000
Origin
Ward 5 (45.5) 3 (17.6) 4 (30.8) 0.627
Emergency room 3 (27.3) 7 (41.2) 5 (38.5)
Surgery 3 (27.3) 7 (41.2) 4 (30.8)
Admission category
Medical infected 4 (36.4) 8 (47.1) 9 (69.2) 0.098
Surgery – urgent 3 (27.3) 5 (29.4) 4 (30.8)
Surgery – elective 4 (36.4) 4 (23.5) 0 (0.0)
Continue...
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Table 1 - Continuation
Variable Group 1
(N=11)
Group 2
(N=17)
Group 3
(N=13)
p value
Comorbidities
Present 6 (54.5) 13 (76.5) 7 (53.8) 0.333
Absent 5 (45.5) 4 (23.5) 6 (46.2)
Type of infection
Community-acquired 4 (36.4) 7 (41.2) 4 (30.8) 0.841
Nosocomial 7 (63.6) 10 (58.8) 9 (69.2)
Focus
Pulmonary 5 (45.5) 12 (70.6) 11 (84.6) 0.260
Intra-abdominal 4 (36.4) 3 (17.6) 2 (15.4)
Urinary 1 (9.1) 2 (11.8) 0 (0.0)
Bloodstream 1 (9.1) 0 (0.0) 0 (0.0)
Organ dysfunction 4.0 (3.0-4.0) 4.0 (3.0-4.0) 3.0 (2.0-4.0) 0.155
>3 dysfunctions 10 (90.9) 16 (94.1) 8 (61.5) 0.054
Mortality 7 (63.6) 10 (58.8) 8 (61.5) 0.967
APACHE, Acute Physiologic and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment; ICU, intensive care unit; T0, admission 
value ; T1, value after 24 hours. Group 1, worsened SOFA; Group 2, improved SOFA; Group 3, unchanged SOFA. The Delta SOFA scores are 
calculated as the T1 SOFA minus the T0 SOFA scores. The results are expressed as medians (25–75% percentiles), means ± standard deviation or 
numbers (%).
Table 2 - Inflammatory parameters according to organ dysfunction progression profile 
Variable Group 1 
(N=11)
Group 2
 (N=17)
Group 3 
(N=13)
p value
IL-6
D0 4,120.0 (243.7–9321.0) 340.0 (127.7–1,178.0) 927.0 (42.7–2,047.5) 0.049
D0 log 3.61 (2.38–3.96) 2.53 (2.13–3.12) 3.10 (1.87–3.33) 0.075
Delta% 4.5 (3.0–39.2) 43.3 (14.9–92.0) 38.8 (6.6–106.1) 0.203
Deltalog% 66.09 (57.8–88.6) 84.8 (71.3–98.8) 87.37 (60.6–101.4) 0.372
Deltasub -3,935.0 (-9,068.1 – -144.2) -63.7 (-455.95 – -4.35) -268.9 (-1,270.0–3.6) 0.097
IL-8
D0 362.1 (280.7–904.1) 109.8 (66.6–333.3) 102.9 (51.0–265.3) 0.001**,††
D0 log 2.55 (2.44–2.95) 2.04 (1.81–2.51) 2.01 (1.63–2.41)  0.001**,††
Delta% 46.5 (38.0–76.5) 65.6 (49.8–195.9) 90.5 (42.7–101.9) 0.094
Deltalog% 86.2 (83.8–95.1) 90.8 (84.2–98.0) 97.7 (84.2–100.4) 0.279
Deltasub -192.7 (-321.9 – -126.0) -31.0 (-169.5–3.95) -5.9 (-99.0–2.5) 0.015*
IL-10
D0 160.1 (61.7–295.0) 63.4 (33.6–123.4) 33.0 (18.0–74.35 0.010**
D0 log 2.20 (1.79–2.47) 1.80 (1.52–2.09) 1.54 (1.29–1.91) 0.019**
Delta% 54.7 (26.8–78.9) 60.0 (39.3–89.3) 80.4(17.8–143.7) 0.586
Deltalog% 88.9 (74.6–94.3) 85.5 (79.5–96.9) 94.1 (60.3–110.3) 0.786
Deltasub -48.6 (-107.7 – -13.0) -18.0 (-73.7 – -1.7) -2.3 (-60.8–12.6) 0.132
CRP
D0 175.8 (129.4–247.1) 136.5 (19.8–183.4) 157.0 (55.3–211.4) 0.171
Delta% 96.4 (71.7(140.6) 99.7 (66.6–129.3) 82.1 (63.6–91.0) 0.103
Deltasub -4.6 (-40.1–72.4) -0.05 (-9.51–27.0) -18.4 (-61.5 – -4.6) 0.077
IL-6, interleukin 6; IL-8, interleukin 8; IL-10, interleukin 10; CRP, C-reactive protein. Group 1, worsened SOFA; Group 2, improved SOFA; Group 
3, unchanged SOFA. Delta% refers to the variable T1 divided by the T0 value (×100). Deltalog% refers to the log value of variable T1 divided by the 
T0 log value (×100). Deltasub refers to the variable T1 value minus the T0 value. The results are expressed as medians (25–75% percentiles). Dunn 
post-test: *, p< 0.05 for Group 1 vs. Group 2; **, p< 0.01 for Group 1 vs. Group 2; †, p< 0.05 for Group 2 vs. Group 3; ††, p< 0.05 for Group 2 
vs. Group 3.
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Figure 1 - Baseline interleukin 6 (IL-6) values and their 
correlation with delta SOFA within the first 24 hours 
(Spearman’s test).
Figure 2 - Baseline interleukin 8 (IL-8) values and their 
correlation with delta SOFA within the first 24 hours 
(Spearman’s test).
Table 3 - Correlation between inflammatory variables and organ dysfunction
Variable SOFA D0 Delta SOFAsub Delta SOFA %
r p value r p value r p value
IL-6
D0 0.017 0.915 0.297 0.059 0.329 0.036
D0 log -0.102 0.536 0.302 0.062 0.328 0.041
Delta% 0.144 0.387 -0.258 0.119 -0.263 0.110
Deltalog% 0.062 0.712 -0.193 0.245 -0.202 0.223
Deltasub 0.037 0.817 -0.292 0.064 -0.322 0.040
IL-8
D0 -0.078 0.627 0.373 0.016 0.394 0.011
D0 log -0.078 0.627 0.373 0.016 0.394 0.011
Delta% -0.065 0.685 -0.227 0.153 -0.258 0.103
Deltalog% -0.048 0.766 -0.086 0.595 -0.101 0.529
Deltasub -0.041 0.797 -0.264 0.095 -0.288 0.068
IL-10
D0 0.027 0.865 0.113 0.481 0.143 0.374
D0 log 0.065 0.689 0.126 0.438 0.158 0.332
Delta% -0.180 0.265 -0.011 0.949 -0.056 0.732
Deltalog% -0.120 0.461 -0.007 0.967 -0.043 0.791
Deltasub -0.170 0.287 -0.052 0.747 -0.081 0.614
CRP
D0 0.177 0.269 0.218 0.172 0.234 0.141
Delta% 0.245 0.123 -0.053 0.742 -0.014 0.932
Deltasub 0.268 0.090 -0.120 0.454 -0.077 0.634
IL-6, interleukin 6; IL-8, interleukin 8; IL-10, interleukin 10; CRP, C-reactive protein; SOFA, Sequential Organ Failure Assessment. Delta% refers 
to the variable T1 divided by the T0 value (×100). Deltalog% refers to the log value of the variable T1 divided by the T0 log value (×100). Deltasub 
refers to the variable T1 value minus the T0 value. The results are expressed as medians (25–75% percentiles).
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DISCUSSION
In this study, we demonstrated that higher baseline IL-
6, IL-8 and IL-10 levels are associated with unfavorable 
organ dysfunction outcomes, as assessed by SOFA scores. 
In addition, increased IL-8 concentrations within the first 
24 hours after inclusion were associated with a worsening 
of this score within this time interval. Additionally, a 
significant although weak correlation was observed with 
worsened SOFA scores and an increase in baseline IL-6 
values. 
Our population consisted of severely ill patients, with 
an advanced median age, high admission SOFA scores 
and multiple organ dysfunctions. Most of the patients 
had more than three organ dysfunctions, and their 
mortality rate was high. In this population, none of the 
demographic variables or sepsis characteristics were shown 
to be associated with the intensity of organ dysfunction 
or progression as assessed with the SOFA score; however, 
baseline cytokine (IL-6, IL-8 and IL-10) concentrations 
were associated with both dysfunction progression and 
intensity, suggesting that these variables are relevant 
severity markers. 
This association between baseline cytokine 
concentrations and the severity of organ dysfunction 
has been previously reported by Kellum, who showed 
that community-acquired pneumonia patients who 
did not develop sepsis had lower IL-6, IL-10 and 
TNF-α concentrations than patients with progressive 
inflammatory response and dysfunction.(9) Obberholzer 
et al. showed a marginally significant association between 
baseline IL-6, IL-10 and TNF-α concentrations and organ 
dysfunction intensity as assessed with the MODS score.(11) 
Bozza et al. reported that IL-8 concentrations were better 
correlated with the severity of organ dysfunction as 
assessed with the SOFA score on the first day of severe 
sepsis or shock diagnosis.(10) Livaditi found that IL-6, IL-8 
and IL-10 concentrations within the first 24 hours after 
sepsis diagnosis were significantly different according to 
the organ dysfunction intensity as assessed with the SOFA 
score;(12) this finding was similar to those reported by 
others.(20) 
However, in this study, we also found an association 
between baseline concentrations and a lower SOFA score 
within a short time period (24 hours). Studies assessing 
the time progression of dysfunction using the SOFA 
or another severity score system are scarce and showed 
inconsistent findings.(21,22) One of the limitations of this 
study regards inappropriate measurements due to the 
fact that these molecules have short half-lives and the 
presence of plasma inhibitors. Kellum et al. reported 
reduced IL-6, IL-10 and TNF-α levels on the second day, 
although the levels remained increased during the first 
week after diagnosis.(9) However, a possible correlation 
of this reduction within 24 hours and short-term organ 
dysfunction progression was not assessed in their study. 
Nguyen et al. stated that reduced IL-6, IL-8, IL-10 and 
TNF-α concentrations were directly associated with 
the capacity for clearing lactate, although a correlation 
between these cytokines and the progression of other 
dysfunctions was not assessed.(13) Bozza et al. identified 
baseline IL-6 and IL-8 concentrations as predictors of 
worsened dysfunction on the third day, i.e., the delta 
SOFA between this day and admission.(10) However, in 
our study, we observed this association occurs earlier, 
with a delta SOFA evident between the first and second 
days. 
Interestingly, cytokines classically described as pro-
inflammatory (IL-6) and anti-inflammatory (IL-10) 
were both associated with the progression of organ 
dysfunction within the first 24 hours. More recent studies 
have argued against the validity of this distinction of 
mediators as being only pro- or anti-inflammatory. For 
example, IL-6 has been associated with both processes, 
clearly showing the duality of some of these mediators 
in the septic process. Appropriate IL-6 concentrations 
have been described as being associated with beneficial 
effects such as protection against bacterial infection, 
the inactivation of pro-inflammatory mediators, 
increased cortisol production and insulin sensitivity. 
However, among the classical cytokines, IL-6 shows the 
best correlation between serum levels and unfavorable 
septic shock outcomes; this has triggered studies on this 
mediator as a severity marker.(23,24)
 Interestingly, in our study, increased IL-8 levels were 
clearly associated with worsened dysfunction within 
24 hours. Previous studies have shown this cytokine to 
have an important role in septic organ dysfunction, in 
particular, acute lung injury and respiratory distress 
syndrome.(25) In addition, Livaditi et al. reported that IL-8 
baseline concentrations in sepsis were more appropriate 
to differentiate patients progressing with shock and to 
discriminate surviving from non-surviving patients.(12) 
Our results thus agree with the relevant literature, 
characterizing this marker as an important organ 
dysfunction mediator in sepsis.
This study has strengths and limitations. First, we 
studied a selected and homogeneous group of patients 
all presenting septic shock during the first hours of 
dysfunction. Cytokine concentrations are known to 
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change during disease progression. Therefore, blood 
samples drawn within the first 48 hours from the 
onset of organ dysfunction, rather than when the first 
hemodynamic changes are identified, render our data 
representative of early sepsis. This perhaps explains our 
statistically significant results despite the small sample 
size. One of the limitations of previous studies is related 
to patients at different sepsis progression times being 
assessed together. 
In our study, the small sample size may be considered 
a limitation. In addition, although the SOFA score is 
widely used, several of its specific components have been 
criticized, e.g., the respiratory component does not take 
into consideration the positive end-expiratory pressure 
(PEEP) level for the assessment of the ratio of arterial 
oxygen pressure to inspired oxygen fraction (PaO2/
FiO2). The renal component does not reflect the current 
Acute Kidney Injury (AKIN)(26,27) classification, and the 
cardiovascular component includes a threshold for the 
dose of noradrenalin that is considered too low by many 
authors. Additionally, the use of deltas has been criticized 
in the literature. Finally, our sample of patients was part of 
another cohort focused on the assessment of coagulation 
and hyperglycemia interactions. Therefore, the inclusion 
and exclusion criteria compromise the external validation 
of our findings.
CONCLUSIONS
Higher baseline IL-6, IL-8 and IL-10 levels are 
associated with unfavorable organ dysfunction outcomes. 
Increased IL-8 levels within the first 24 hours are 
correlated with worsening dysfunction. Our findings may 
contribute to a better understanding of the physiology of 
septic shock. 
Study conducted at Universidade Federal de São Paulo – 
UNIFESP – São Paulo (SP), Brazil.
RESUMO
Objetivo: Analisar o comportamento das disfunções orgâni-
cas e sua correlação com a resposta inflamatória, avaliada pelas 
concentrações basais de citocinas e pela evolução dessas concen-
trações, na fase precoce do choque séptico.
Métodos: Foram avaliados pacientes com idade acima de 18 
anos e diagnóstico de choque séptico com menos de 48 horas de 
início das disfunções orgânicas. Foram mensuradas interleucina 
6 (IL-6), interleucina 8 (IL-8), interleucina 10 (IL-10) e protei-
na C reativa na inclusão e após 24 horas, sendo calculado o delta 
desses valores. A evolução das disfunções orgânicas foi avaliada 
através do escore Sequential Organ Failure Assessment (SOFA) 
na admissão e após 24 horas para determinação do delta SOFA, 
posteriormente categorizado como piora ou melhora. Os resul-
tados foram expressos como média ± desvio padrão ou mediana 
(percentil 25%-75%). Consideraram-se significativos resultados 
com valor descritivo de p menor que 0,05.
Resultados: Foram incluídos 41 pacientes com mediana 
do SOFA de 8,0(6,5 -10,0) e 8,0(6,0-10,0) na admissão (T0) 
e após 24 horas (T1). Piora, melhora ou ausência de alteração 
do SOFA foram encontradas respectivamente em 11 (Grupo 1), 
17 (Grupo 2) e 13 pacientes (Grupo 3). No grupo 1 os valores 
basais de IL-6, IL-8 e IL-10 foram mais elevados. No Grupo 1 
houve aumento significativo de IL-8 após 24 horas. A variação 
do SOFA após 24 horas mostrou correlação significativa, embo-
ra fraca, com as concentrações basais de IL-6 e IL-8. 
Conclusão: As concentrações basais mais elevadas de IL-6, 
IL-8 e IL-10 associam-se a evolução desfavorável da disfunção 
orgânica. A elevação das concentrações de IL-8 nas primeiras 24 
horas mostrou-se correlacionada a piora dessa disfunção. 
Descritores: Choque séptico; Insuficiência de múltiplos órgãos/
etiologia; Síndrome de resposta inflamatória sistêmica; Citocinas 
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